Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVEREST: Verteporfin PDT +/- Ranibizumab in PCV
NCT00674323Phase 4Completed
- Sponsor
- Novartis
- Start
- Apr 2008
- Primary completion
- May 2009
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 4 trial of ranibizumab, verteporfin in polypoidal choroidal vasculopathy (PCV), sponsored by Novartis. Started Apr 2008; status: completed.
02
Drugs
ranibizumabverteporfin
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT00674323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00674323.